Clearance Summary
ALPHA-BSM, BETA-BSM, GAMMA-BSM, EQUIVABONE received FDA 510(k) clearance under submission number K091729, sponsored by Etex Corp.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Dental review panel. The statutory decision date of record is 2009-12-23.
- Submission: K091729
- Applicant / Sponsor: Etex Corp.
- Clearance pathway: Traditional
- Review panel: Dental
- Device class: Class II
- Regulation citation: 21 CFR 872.3930
- Decision date: 2009-12-23
Classification & Regulation
This clearance is catalogued under FDA product code LYC and 21 CFR 872.3930, within the Dental review panel as a Class II device.